SCHEMBL2918896

SCHEMBL2918896

CCOC(=O)c1nn(-c2cccnc2)c(-c2ccccc2)c1C

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.60
CYP3A4 P08684 1/20 0.60
CYP2C9 P11712 1/20 0.60
CYP2C19 P33261 1/20 0.60
NPC1 O15118 2/20 0.54
RAB9A P51151 2/20 0.54
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
NPSR1 Q6W5P4 3/20 0.53
KDM4E B2RXH2 3/20 0.51
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
HPGD P15428 1/20 0.50
HSD17B10 Q99714 1/20 0.50
GABRA2 P47869 1/20 0.48
GABRB2 P47870 1/20 0.48
TP53 P04637 1/20 0.47
ALOX12 P18054 1/20 0.47
APP P05067 1/20 0.46
MAPT P10636 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2919412 0.89 ALDH1A1 (0.73) ALDH1A1CYP3A4CYP2C9CYP2C19NPC1
SCHEMBL18353617 0.87 ALDH1A1 (0.64) ALDH1A1CYP3A4CYP2C9CYP2C19NPC1
SCHEMBL2918377 0.86 CNR1 (0.51) ALDH1A1CYP3A4CYP2C9CYP2C19CA1
SCHEMBL16876827 0.82 ALDH1A1 (0.46) ALDH1A1CYP3A4CYP2C9CYP2C19NPC1
SCHEMBL29838942 0.81 ALDH1A1 (0.63) ALDH1A1CYP3A4CYP2C9CYP2C19NPC1
SCHEMBL16883790 0.79 NPC1 (0.53) ALDH1A1CYP3A4CYP2C9CYP2C19NPC1
SCHEMBL4158179 0.78 MEN1 (0.50) ALDH1A1CYP3A4CYP2C9CYP2C19NPC1
SCHEMBL2918809 0.77 ALDH1A1 (0.70) ALDH1A1CYP3A4CYP2C9CYP2C19NPC1
SCHEMBL16876864 0.77 ALDH1A1 (0.46) ALDH1A1CYP3A4CYP2C9CYP2C19NPC1
SCHEMBL4161662 0.77 MEN1 (0.54) ALDH1A1CYP3A4CYP2C9CYP2C19NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1591443-B1 PYRAZOLE DERIVATIVE DAIICHI SANKYO CO LTD (JP) 2010-08-25 EP disclosed
US-7622471-B2 Pyrazole derivatives having a pyridazine and pyridine functionality DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2009-11-24 US disclosed
US-7622471-B2 Pyrazole derivatives having a pyridazine and pyridine functionality DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2009-11-24 US disclosed
US-20060128685-A1 Pyrazole derivative DAIICHI PHARMACEUTICAL CO., LTD., (JP) 2006-06-15 US disclosed
EP-1591443-A1 PYRAZOLE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060128685-A1 Pyrazole derivative PTGS1, PTGS2, PTGER1 ALDH1A1 139/4885CYP3A4 380/4885CYP2C9 251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.